Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$154.79 - $180.76 $4.53 Million - $5.29 Million
29,271 New
29,271 $5.02 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $1.24 Million - $1.39 Million
8,993 New
8,993 $1.39 Million
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $5.4 Million - $6.21 Million
37,316 New
37,316 $5.95 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $30.3 Million - $37.6 Million
-229,357 Reduced 79.1%
60,586 $9.82 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $27.6 Million - $31.3 Million
259,493 Added 852.19%
289,943 $31.3 Million
Q2 2021

Aug 13, 2021

BUY
$105.21 - $117.21 $3.2 Million - $3.57 Million
30,450 New
30,450 $3.43 Million
Q1 2021

May 14, 2021

SELL
$102.3 - $112.62 $15.9 Million - $17.5 Million
-155,225 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$80.49 - $108.67 $12.5 Million - $16.9 Million
155,225 New
155,225 $16.6 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $1.07 Million - $1.26 Million
-12,500 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $843,755 - $1.13 Million
11,500 Added 1150.0%
12,500 $1.23 Million
Q3 2019

Nov 13, 2019

SELL
$62.98 - $75.72 $20.3 Million - $24.4 Million
-322,863 Reduced 99.69%
1,000 $76,000
Q2 2019

Aug 13, 2019

BUY
$65.7 - $83.98 $20.1 Million - $25.7 Million
306,522 Added 1767.61%
323,863 $23.6 Million
Q4 2018

Feb 14, 2019

SELL
$77.85 - $96.01 $18.5 Million - $22.8 Million
-237,205 Reduced 93.19%
17,341 $1.6 Million
Q3 2018

Nov 13, 2018

SELL
$88.91 - $98.84 $6.74 Million - $7.49 Million
-75,769 Reduced 22.94%
254,546 $24.1 Million
Q2 2018

Aug 13, 2018

SELL
$89.78 - $106.23 $2.85 Million - $3.37 Million
-31,757 Reduced 8.77%
330,315 $30.6 Million
Q1 2018

May 14, 2018

BUY
$92.01 - $123.21 $31.7 Million - $42.4 Million
344,076 Added 1911.96%
362,072 $34.3 Million
Q3 2017

Nov 13, 2017

BUY
$69.85 - $89.22 $1.26 Million - $1.61 Million
17,996
17,996 $1.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Laurion Capital Management LP Portfolio

Follow Laurion Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Laurion Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Laurion Capital Management LP with notifications on news.